🔎 Trials Near Me

Hjem › Pankreaskreft › Wisconsin

Kliniske studier for Pankreaskreft i Wisconsin

29 studier for Pankreaskreft søker deltakere på steder i Wisconsin.

Byer i Wisconsin

Offisiell studietekst (engelsk)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Zablocki Veterans Administration Medical Center, Milwaukee
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • University of Wisconsin Carbone Cancer Center, Madison
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05372614

Pancreatic Cancer Detection Consortium

  • Medical College of Wisconsin, Milwaukee
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06388967

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US044, Madison
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07522073

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0134, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07492680

Promoting CT Engagement for Pancreatic Cancer With App

  • Medical College Of Wisconsin, Milwaukee
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06252545

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Children's Hospital of Wisconsin, Milwaukee
RekruttererObservasjonsstudie
Opp til 17 år · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06651580

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Aurora Saint Luke's South Shore, Cudahy
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • og 23 flere
RekruttererObservasjonsstudie
Alder 50 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT04239573

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • UW Health, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07644559

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04172532

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT06582017

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Aurora Saint Luke's South Shore, Cudahy
  • og 28 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06958328

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • og 10 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT06998940

Determining Individualized Cancer Therapy in Pancreatic Cancer

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT05914987

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT06228599

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

  • Marshfield Medical Center-Marshfield, Marshfield
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 31. mar. 2026 · NCT06807437

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

  • Froedtert & the Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04683315

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  • Medical College of Wisconsin, Milwaukee
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04075305

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University Telemedicine, Chippewa Falls
  • Ohio State University Telemedicine, Green Bay
  • Ohio State University Telemedicine, Madison
  • og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06906562

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Saint Elizabeth Hospital, Appleton
  • Ascension Southeast Wisconsin Hospital - Elmbrook Campus, Brookfield
  • og 35 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06073431

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

  • Froedtert & the Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jan. 2026 · NCT03322995

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • University of Wisconsin, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jun. 2025 · NCT03175224

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 6. nov. 2024 · NCT05254171

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.